Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
22 hedge funds and large institutions have $1.08M invested in Biotricity, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 6 closing their positions.
450% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 2
4% less funds holding
Funds holding: 23 → 22 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
42% less capital invested
Capital invested by funds: $1.85M → $1.08M (-$774K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.8K |
| 2 |
CMA
Cedar Mountain Advisors
Lake Oswego,
Oregon
|
+$6.04K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$3.05K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.77K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SWMP
Signature Wealth Management Partners
Montvale,
New Jersey
|
-$24.1K |
| 2 |
Charles Schwab
San Francisco,
California
|
-$10.2K |
| 3 |
Jane Street
New York
|
-$6.53K |
| 4 |
MC
Moors & Cabot
Boston,
Massachusetts
|
-$6.38K |
| 5 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
-$6.38K |
BTCY Hedge Fund Activity: Q3 2023 in Review
22 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q3 2023, worth a combined $1.08M — down 42% from $1.85M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BTCY and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 11 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $73.8K. The largest seller was Signature Wealth Management Partners, exiting entirely with an estimated $24.1K sold.
- 22 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q3 2023, down from 23 in Q2 2023.
- Funds reported $1.08M of Biotricity, Inc. Common Stock stock for Q3 2023, down 42% quarter-over-quarter.
- 5 funds opened new Biotricity, Inc. Common Stock positions in Q3 2023 and 6 closed out, a net change of -1 holder.
- The largest Biotricity, Inc. Common Stock buyer in Q3 2023 was Susquehanna International Group, an estimated $73.8K added.
- The largest Biotricity, Inc. Common Stock seller in Q3 2023 was Signature Wealth Management Partners, an estimated $24.1K sold.
Based on aggregated 13F filings for Q3 2023.